Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 261 Neoplasms 143 Breast Neoplasms 140 Colorectal Neoplasms 124 Prostatic Neoplasms 94 Neoplasm Metastasis 93 Multiple Myeloma 92 Ovarian Neoplasms 91 Lung Neoplasms 86 Squamous Cell Carcinoma of Head and Neck 62 Pancreatic Neoplasms 62 Recurrence 59 Endometrial Neoplasms 55 Melanoma 52 Small Cell Lung Carcinoma 51 Leukemia, Lymphocytic, Chronic, B-Cell 48 Stomach Neoplasms 47 Carcinoma, Renal Cell 46 Leukemia, Myeloid, Acute 44 Lymphoma, Non-Hodgkin 40 Advanced Solid Tumors 39 Urinary Bladder Neoplasms 37 Triple Negative Breast Neoplasms 36 Parkinson Disease 4, Autosomal Dominant Lewy Body 36 Lymphoma, Large B-Cell, Diffuse 36 Head and Neck Neoplasms 36 Carcinoma, Hepatocellular 35 Lymphoma, Follicular 30 Esophageal Neoplasms 30 Myasthenia Gravis 27

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Anal Cancer Metastatic × 30 days × Clear all

NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡